<DOC>
	<DOCNO>NCT01072058</DOCNO>
	<brief_summary>The purpose study determine possible alteration cardiac function patient Rheumatoid Arthritis Ankylosing Spondylitis anti-TNF therapy , without clinical heart disfunction baseline , use highly sensitive non-invasive method .</brief_summary>
	<brief_title>Heart Function Rheumatoid Arthritis Ankylosing Spondylitis Pre Post-TNF Blocker</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Diagnosis Rheumatoid Arthritis eligible receive TNF blocker Diagnosis Ankylosing Spondylitis eligible receive TNF blocker Clinical heart failure Chagas'disease Stable unstable angina Past history myocardial infarct Systemic Ã¡rterial hypertension ( grade 3 ) Valvulopathy Chronic kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Infliximab</keyword>
	<keyword>Adalimumab</keyword>
	<keyword>Etanercept</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Diastolic disfunction</keyword>
	<keyword>TNF blocker</keyword>
	<keyword>Anti-TNF</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>Tissue doppler imaging</keyword>
	<keyword>Brain Natriuretic Peptide</keyword>
	<keyword>NT-proBNP</keyword>
</DOC>